BioSpace News Archive

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that its President and Chief Executive Officer, Jayson Dallas, M.D., will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 12, 2020 at 10:55 a.m. E.T. A live webcast of the presentation will be accessibl

Bruker Corporation announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock.

Orthopedic surgical robots are created to help orthopedic surgeons perform surgeries.

The home diagnostics market may observe an era of cutting-edge technological developments and an escalated growth rate across the forecast period of 2020-2030.

The disinfection robots market may see a silver lining in terms of growth across the forecast period of 2020-2030 on the basis of the soaring demand from diverse applications across the world.

Biosimilars can be defined as a biologic medical product, which is considered to be similar to already approved biologic.

Olympus Corporation announced it has signed a definitive agreement to acquire Arc Medical Design Limited, a subsidiary of Norgine B.V.

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with the Liverpool School of Tropical Medicine (“LSTM”) to clinically validate the rapid, saliva-based coronavirus antigen test that Avacta is developing with Cytiva.